| Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
|---|
| 01/18/2006 | CN1721414A Process for synthesizing 2-p-trifluoro toluene-4-methyl-5-thiazolyl ethyl formate |
| 01/18/2006 | CN1721401A Inhibitors of LFA-1 binding to ICAMS and uses thereof |
| 01/18/2006 | CN1237051C Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 01/17/2006 | US6987120 Pharmaceutical compounds |
| 01/17/2006 | US6987112 Organic compound having cyano group and insecticides/miticides |
| 01/12/2006 | WO2006003495A1 Substituted heteroaryl- and phenylsulfamoyl compounds |
| 01/12/2006 | WO2006003471A2 Process for the preparation of pramipexole by chiral chromatography |
| 01/12/2006 | WO2006003329A1 Collection of traceable compounds and uses thereof |
| 01/12/2006 | WO2005094810A3 Novel pharmaceutical compositions |
| 01/12/2006 | US20060009511 N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor |
| 01/12/2006 | US20060009461 Acetamides and benzamides that are useful in treating sexual dysfunction |
| 01/12/2006 | US20060008835 PNA monomer and precursor |
| 01/12/2006 | CA2573193A1 Substituted heteroaryl- and phenylsulfamoyl compounds |
| 01/12/2006 | CA2569589A1 Method of obtaining 2-amino-6-alkyl-amino-4,5,6,7-tetrahydrobenzothiazoles |
| 01/12/2006 | CA2569545A1 Collection of traceable compounds and uses thereof |
| 01/12/2006 | CA2553311A1 Improved process for the preparation of biologically active tetrahydrobenzthiazole derivative |
| 01/11/2006 | EP1614678A2 Sulfur substituted sulfonylaminocarboxylic acid N-heteroarylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 01/11/2006 | EP1613326A1 (3-{3-´(2,4-bis-trifluormethyl-benzyl)-(5-ethyl-pyrimidin-2-yl)-amino!-propoxy}-phenyl)-acetic acid and related compounds as modulators of ppars and methods of treating metabolic disorders |
| 01/11/2006 | EP1613319A2 Substituted phenyl acetamides and their use as protease inhibitors |
| 01/11/2006 | EP1395572B1 Process for preparing a thiazole ppar-ligand and polymorphs thereof |
| 01/11/2006 | EP1392718B1 Improved native chemical ligation with three or more components |
| 01/11/2006 | EP1358169B1 Diaminothiazoles and their use as inhibitors of cyclin-dependent kinase |
| 01/11/2006 | EP1256342B1 Hypoglycemics comprising organic zinc (ii) complexes |
| 01/11/2006 | EP1131310B1 Chrystals of 5- 6-(2-fluorobenzyl)oxy-2-naphthyl methyl]-2,4-thiazolidinedione |
| 01/11/2006 | EP1056732B1 4-aminothiazole derivatives, their preparation and their use as inhibitors of cyclin-dependent kinases |
| 01/11/2006 | EP1037632B1 Benzothiazole protein tyrosine kinase inhibitors |
| 01/11/2006 | CN1235891C Process for producing substituted alkylamine derivative |
| 01/11/2006 | CN1235890C Thizaolyl amide derivatives |
| 01/11/2006 | CN1235889C Cyanomethylene compounds, process for producing the same, and agricultural or horticultural bactericide |
| 01/11/2006 | CN1235870C Novel use of phenyl hetero alkylamine derivatives |
| 01/11/2006 | CN1235586C Improved releasing composition and use thereof |
| 01/10/2006 | US6984462 Organic electroluminescent devices using double-spiro organic compounds |
| 01/05/2006 | WO2006000323A1 Novel hexafluoroisopropanol derivatives |
| 01/05/2006 | WO2006000288A1 Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes |
| 01/05/2006 | US20060004196 Method for producing heterocyclic fluoroalkenyl sulfones |
| 01/05/2006 | US20060004093 obesity; antidiabetic agents; Alzheimer's disease; Huntington's disease;schizophrenia; anticancer agents; psoriasis; antiepileptic agents; strokes |
| 01/05/2006 | US20060004068 Novel hexafluoroisopropanol derivatives |
| 01/05/2006 | US20060004067 N-(2-chloro-6-methylphenyl)-2-(6-(4-(3-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide; high efficiency, high yield process to get 2-aminothiazole-5-carboxamides using halogention reaction; by-products inhibition; anticancer, psoriasis |
| 01/05/2006 | US20060004066 Method for treating ADAMTS-5-associated disease |
| 01/05/2006 | US20060004065 5,5,7,9,13-%-Pentamethyl-16-[1-methyl-2-(2-methyl)-1,3-thiazol-4-yl)-ethenyl]-6,6-dioxo-1-ox-a-6 lambda 6-thia-cyclohexadeca-10,13-dien-2-one; epothilones and derivatives; improved properties; anticarcinogenic, -tumor agents |
| 01/05/2006 | US20060004063 Inhibitors of HCV NS5B polymerase |
| 01/05/2006 | US20060004062 Compounds for inhibiting insulin secretion and methods related thereto |
| 01/05/2006 | US20060004059 Substituted heterocycles for the treatment of diabetes and other diseases |
| 01/05/2006 | US20060004012 antidiabetic agents for treatment of type II diabetes |
| 01/05/2006 | US20060003986 Such as 4-(4-Methoxy-7-morpholin-4-yl-benzothiazol-2-ylcarbamoyl)-piperidine-1-carboxylic acid tert-butyl ester; for prevention of illnesses based on the modulation of the adenosine system, such as Alzheimer's disease, Parkinson's disease, neuroprotection, schizophrenia, anxiety, pain |
| 01/05/2006 | US20060003374 Coupling amine terminated PNA oligomer or an amine terminated cleavable linker on a solid phase synthesis resin with a benzothiole-2-sulfonyl derivative, capping unprotected amine with actetic anhydride, cleaving over reacted acetyl group, deprotecting benzothiole-2-sulfonyl group, repeating above steps |
| 01/05/2006 | DE102004053311B3 Preparation of thiazolidine compounds, useful as intermediates for pharmaceutically active substances, comprises conversion of acid compounds to their corresponding ester compounds, followed by reaction with pivalaldehyde in situ |
| 01/05/2006 | CA2588571A1 Insulin secretagogue drugs |
| 01/05/2006 | CA2572153A1 Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes |
| 01/05/2006 | CA2571356A1 Novel hexafluoroisopropanol derivatives |
| 01/04/2006 | EP1612208A2 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation |
| 01/04/2006 | EP1612204A1 Hydrazone derivative |
| 01/04/2006 | EP1611120A1 Novel methods for the treatment of inflammatory diseases |
| 01/04/2006 | EP1611115A1 Benzothiazole derivative compounds, compositions and uses |
| 01/04/2006 | EP1611091A1 Novel compounds |
| 01/04/2006 | EP1611088A2 Hydroxamates as therapeutic agents |
| 01/04/2006 | EP1610812A1 Pharmaceutical preparations comprising acid-stabilised insulin |
| 01/04/2006 | EP1610792A1 Calcium channel blockers comprising two benzhydril moieties |
| 01/04/2006 | EP1610790A2 Anticancer compounds |
| 01/04/2006 | EP1610780A2 Cyclic protein tyrosine kinase inhibitors |
| 01/04/2006 | EP1296979B1 HETeroARYL-SUBSTITUTED HETEROCYCLES and their use as pesticides |
| 01/04/2006 | EP1169298B1 Pharmaceutical compounds |
| 01/04/2006 | CN1715274A Double heterocyclic tri azene compound and its preparing method and use |
| 01/04/2006 | CN1234358C Benzothiazole derivatives |
| 01/03/2006 | US6982348 for example, N[(1RS2SR)-2-(4-fluorophenyl)-2-hydroxy-1-[4-fluoromethyl)benzyl]ethyl]-6,7-dihydro-5H-benzo[a]cycloheptene-1-carboxamide; cholesteryl ester transfer protein inhibitory action; lipid-lowering agents |
| 01/03/2006 | US6982335 Synthesis of substituted thiazoline carboxylic acids |
| 01/03/2006 | US6982332 Hybrid 2-aminotetralin and aryl-substituted piperazine compounds and their use in altering CNS activity |
| 01/03/2006 | US6982277 Antitumor agents, antiinflammatory agents; for example 2-(2-imino-4,5,6,7-tetrahydro-1,3-benzothiazol-3(2H)-yl)-1-(4-methylphenyl) -1-ethanone, 2-(4-methylphenyl)-5,6,7,8-tetrahydrobenzo(d)-imidazo(2,1-b)thiazole |
| 01/03/2006 | US6982275 Oxidizing a benzylthio- or pyridylmethylthio-substituted indole or benzimidazole derivative |
| 01/03/2006 | CA2235747C Use of 1-(2-naphth-2-ylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine for preparing drugs for treating amyotrophic lateral sclerosis |
| 12/29/2005 | WO2005123727A1 3-aryl-3-hydroxy- and 3-aryl-3-oxopropionic acid esters as fungicides |
| 12/29/2005 | WO2005123704A1 Compound for preparing thiazole by aminomethylation |
| 12/29/2005 | WO2005123703A2 Alkynyl derivatives as modulators of metabotropic glutamate receptors |
| 12/29/2005 | WO2005051974A3 Novel molecules for regulating cell death |
| 12/29/2005 | WO2005025356A3 Orthopedic insoles for protecting skin from stretching and cracking in the area of the five metatarsal heads of the forefoot |
| 12/29/2005 | US20050288501 Reducing a 2-(protected amino)-3-(piperazin-1-yl, N-morpholinyl, or N-thiomorpholinyl) propanoate, deprotecting the amine, and reacting with t-butylisothiocyanate |
| 12/29/2005 | US20050288376 Bicyclyl or heterobicyclylmethanesulfonylanimo-substituted N-hydroxyformamides |
| 12/29/2005 | US20050288350 Useful in female hormone replacement therapy and as modulators of fertility; therapy of dysfunctional uterine bleeding, dysmenorrhea, endometriosis, leiomyomas (uterine fibroids), hot flashes, mood disorders, meningiomas, cancer; 6-(bis-2,2,2-Trifluoroethyl)amino-4-trifluoromethylcoumarin |
| 12/29/2005 | US20050288340 Substituted heteroaryl- and phenylsulfamoyl compounds |
| 12/29/2005 | US20050288303 Cyclic protein tyrosine kinase inhibitors |
| 12/29/2005 | US20050288282 Anticancer agents; antiproliferative agents |
| 12/29/2005 | US20050288238 Benzocyclodecane derivatives with antitumor activity |
| 12/29/2005 | US20050288186 1-(4-{3-[2,6-Dichloro-4-(3,3-dichloro-allyloxy)-phenoxy]-propoxy}-phenyl)-1H-pyrrole, for example; protecting soybean plants against pests such as caterpillars |
| 12/28/2005 | EP1609362A2 Non-systemic control of parasites |
| 12/28/2005 | EP1608662A1 Guanidine derivatives and use thereof as neuropeptide ff receptor antagonists |
| 12/28/2005 | EP1608647A1 5-phenylthiazole derivatives and their use as p13 kinase inhibitors |
| 12/28/2005 | EP1608619A1 Muscarinic agonists |
| 12/28/2005 | EP1434779B1 Cross-linked glycopeptide-cephalosporin antibiotics |
| 12/28/2005 | EP1299352B1 Compounds to treat alzheimer's disease |
| 12/28/2005 | EP1263746B1 Substituted 8, 8a-dihydro-3ah-indeno 1,2-d]thiazoles, a method for their production and their use as medicaments |
| 12/28/2005 | EP1224183B1 Heterocyclic sodium/proton exchange inhibitors and method |
| 12/28/2005 | EP1178043B1 Method for storing quaternary ammonium salt |
| 12/28/2005 | EP1124810B9 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 12/28/2005 | EP1085810B1 Agents for combatting plant pests |
| 12/28/2005 | EP1031563B1 Sulfonyl derivatives |
| 12/28/2005 | CN1714074A Process for producing aromatic nitrile compound |
| 12/28/2005 | CN1714070A Vitamin d receptor modulators |
| 12/27/2005 | US6979747 Antioxidants, preparation processes and their uses |
| 12/27/2005 | US6979694 Drugs such as (5-(((2,4,6-Trimethylphenyl)amino)carbonyl)-4-methyl-2-thiazolyl)carbamic acid, 1,1-dimethylethyl ester, used as enzyme inhibitors, for prohylaxis of inflammatory bowel disease; modulation of immunology |
| 12/27/2005 | US6979575 benzo[c,d]indolium derivative containing a quaternary ammonium or ammonium salt; used as fluorescent marker dye; a biomolecule labeled with the fluorescent marker dye |